Digoxin

DB00390ApprovedInvestigationalSmall moleculeCardiac GlycosidesCardiotonic Agents

Digoxin is a cardiac glycoside used in the treatment of mild to moderate heart failure and for ventricular response rate control in chronic atrial fibrillation. Digoxin is one of the oldest cardiovascular medications used today.

Chemical structure of Digoxin
Mechanism
Curator reviewed · 10 references
Primary indication
Digoxin is indicated in the following conditions: 1) For the treatment of mild to moderate heart failure in adult patients.Curator reviewed · 3 structured indications
Formula / weight
C41H64O14 · 780.9385 g/mol (avg)
First approval
Canada, 2005 · United States, 1975
Code names
NSC-95100
Brand names
  • Digox
  • Lanoxin

Resolves to

Structure
InChIKeyLTMHDMANZUZIPE-PUGKRICDSA-NSMILES[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1

What you can answer from here — as of September 16, 2026

7Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
7TransportersSubstrate / inhibitor direction, not just membership
Listed above
1,708Drug interactionsStructured to mechanism, not free text
Sign in
171Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
3ContraindicationsEach with its own population and attribute set
Sign in
306Marketed productsAcross 10 countries and 98 labellers
Sign in
1ATC codeIncluding every combination product, plus 31 drug categories
Sign in
86+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Digoxin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account